Key result
Catheter ablation of left ventricular tachycardia via the transseptal approach from the right internal jugular vein was demonstrated to be safe and feasible.
Why the study?
Is catheter ablation of left ventricular tachycardia via the transseptal approach from the right internal jugular vein safe and feasible?
Case Report
Is catheter ablation of left ventricular tachycardia via the transseptal approach from the right internal jugular vein safe and feasible?
Demonstrates a novel transseptal approach from the right internal jugular vein for LV VT ablation, offering an alternative when femoral access is precluded.
Transseptal LV access may aid VT ablation when retrograde is limited by vascular or valve disease; leaves open need for comparative outcome data.
A retrograde approach to the left ventricle (LV) from the femoral artery is most commonly used for left ventricular tachycardia (VT) ablation. However, as the patient population gets older, the prevalence of peripheral vascular disease and aortic valve disease increases, hampering the retrograde access to the LV, which may result in significant technical difficulties. The transseptal approach from the femoral vein is an alternative access to the LV. This approach has been effective for addressing LV VT originating from the posterior and posteroseptal region. However, the transseptal approach from the femoral vein is impossible if there are any obstacles in the inferior vena cava. There are also significant limitations in approaching the basal-lateral region of the LV from this approach. We demonstrated the safety and feasibility of catheter ablation of LV VT via the transseptal approach from the right internal jugular vein.
No takes yet. Share an insight, caveat, or question.
Han et al. (2012) conducted a case report in Left ventricular tachycardia. Catheter ablation via transseptal approach from the right internal jugular vein was evaluated on Safety and feasibility. Catheter ablation of left ventricular tachycardia via the transseptal approach from the right internal jugular vein was demonstrated to be safe and feasible.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: